Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Controlled Substances topic
No spam. Unsubscribe anytime.
Committee sends controlled-substances unifier (House Bill 29) to the floor with a do-pass recommendation
Summary
Representative Marco Erickson presented House Bill 29, the annual update to Idaho's controlled substances scheduling. The committee voted to send the bill to the House floor with a do-pass recommendation; sponsor answered a question about the scheduling of a postpartum depression medication.
Representative Marco Erickson (R–District 33) presented House Bill 29, the annual update to Idaho’s Controlled Substances Act schedules. The committee voted to send the bill to the House floor with a do-pass recommendation.
Erickson said Idaho is one of 12 states that maintains its own drug scheduling process rather than incorporating federal schedules by reference; the state's independent review can yield different classifications where Idaho’s panel deems it appropriate. The bill updates scheduling for specified substances in Idaho’s statute.
Representative McCain asked about the scheduling of the drug zuranolon, a medication for postpartum depression. Erickson said scheduling a newly marketed drug is standard practice and that zuranolon was being placed in schedule 4, a category that recognizes medical use while enabling monitoring.
Representative Redmond moved to send House Bill 29 to the floor with a do-pass recommendation. The committee approved the motion by voice vote and designated Representative Erickson as the floor sponsor. No public testimony was recorded during the committee action.
